Evidence map›Paper›PMID 37861386›Full record

ArticleOncotarget2023

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.

Devalingam Mahalingam, Salih Hanni, Anthony V Serritella, Christos Fountzilas, Joel Michalek, Brian Hernandez, John Sarantopoulos, Paromitta Datta, Ofelia Romero, Sureshkumar Mulampurath Achutan Pillai and 3 more

Open access · diamondAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Devalingam MahalingamDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Salih HanniDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Anthony V SerritellaRobert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Christos FountzilasDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Joel MichalekDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Brian HernandezDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
John SarantopoulosInstitute for Drug Development, Mays Cancer Center at University of Texas Health, San Antonio, TX 78229, USA.
Paromitta DattaAudie Murphy VA Hospital, San Antonio, TX 78229, USA.
Ofelia RomeroDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Sureshkumar Mulampurath Achutan PillaiDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
John KuhnDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Michael PollakDivision of Experimental Medicine, Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, Canada.
Ian M ThompsonDivision of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
The University of Texas Health Science Center at San Antonio · USNorthwestern University · USAudie L. Murphy Memorial VA Hospital · USMays Cancer Center at UT Health San AntonioMcGill University · CARoswell Park Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37861386
PMCPMC10588661
OpenAlexW4387787565

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.